FOLFIRI Clinical Trials
14 recruitingDrug
Phase 19Phase 25Phase 32
Showing 1–14 of 14 trials
Recruiting
Phase 1
A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)
Metastatic Colorectal Cancer
Hoffmann-La Roche542 enrolled76 locationsNCT04929223
Recruiting
Phase 2
FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer
Ras-mutated Metastatic Colorectal Cancer
Oncolytics Biotech60 enrolled1 locationNCT07446322
Recruiting
Phase 1Phase 2
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Non-small Cell Lung CancerMetastatic Lung CancerMetastatic Lung Non-Small Cell Carcinoma+18 more
Institut de Recherches Internationales Servier554 enrolled11 locationsNCT05786924
Recruiting
Phase 1
A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers
Colorectal NeoplasmsGastrointestinal Neoplasms
Janssen Research & Development, LLC220 enrolled10 locationsNCT06663319
Recruiting
Phase 2Phase 3
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
Untreated, Unresectable, or Metastatic Colorectal Cancer
Bristol-Myers Squibb990 enrolled263 locationsNCT07221357
Recruiting
Phase 1
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
Solid Tumors
Incyte Corporation710 enrolled34 locationsNCT06179160
Recruiting
Phase 1
Response Adapted Neoadjuvant Therapy in Gastroesophageal Cancers (RANT-GC Trial)
Gastroesophageal Adenocarcinoma
University of California, Irvine20 enrolled1 locationNCT05733689
Recruiting
Phase 1
TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers
Cancer
Tizona Therapeutics, Inc240 enrolled41 locationsNCT04485013
Recruiting
Phase 1
A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors
Solid TumorsAdvanced Solid TumorsMetastatic Solid Tumors
Incyte Corporation408 enrolled36 locationsNCT05836324
Recruiting
Phase 3
Post-resection/Ablation Chemotherapy in Patients With Metastatic Colorectal Cancer (FIRE-9 - PORT / AIO-KRK-0418)
Dominik Paul Modest507 enrolled79 locationsNCT05008809
Recruiting
Phase 2
Maintenance Niraparib Plus Ipilimumab in Patients With Metastatic Pancreatic Adenocarcinoma Whose Disease Has Not Progressed on Platinum-Based Chemotherapy
Pancreatic Adenocarcinoma Metastatic
Abramson Cancer Center at Penn Medicine68 enrolled2 locationsNCT06747845
Recruiting
Phase 1
Trial of ProAgio in Advanced/Metastatic Colorectal Cancer
Metastatic Colorectal CancerAdvanced Colorectal Cancer
University of Alabama at Birmingham27 enrolled1 locationNCT06867822
Recruiting
Phase 2
A Study of PM8002 in Combination With Chemotherapy in Patients With NEN
Neuroendocrine Neoplasm
Biotheus Inc.60 enrolled13 locationsNCT05879055
Recruiting
Phase 1
alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells
Unresectable Metastatic Colorectal Cancer
Celyad Oncology SA49 enrolled4 locationsNCT03692429